The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE
Launched by E-DA HOSPITAL · Apr 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying Barrett's Esophagus (BE), a condition where the lining of the esophagus changes, which can lead to more serious health issues. The researchers want to find out the best way to take biopsies, which are small samples of tissue, to see if there are any harmful changes called dysplasia or the presence of goblet cells. They are particularly focused on understanding how many biopsies are needed and how effective they are in detecting these changes, especially in Asia.
To participate in this study, you need to be an adult with a specific type of esophagus lining called a columnar-lined esophagus. However, you cannot join if you have had certain previous treatments for Barrett's Esophagus, any history of cancer in the upper digestive tract, or if you have certain medical conditions that could complicate the procedure. If you decide to participate, you can expect to undergo biopsies as part of the evaluation process, which will help improve the understanding and management of Barrett's Esophagus for future patients. The study is currently recruiting participants of all genders, and it aims to gather important information that could lead to better care for those with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults with columnar-lined esophagus
- Exclusion Criteria:
- • A prior history of endoscopic treatment for Barrett's Esophagus
- • A prior history of upper gastrointestinal malignancy
- • A prior history of total or subtotal gastrectomy
- • Esophageal varices noted during the procedure
- • Uncontrolled coagulopathy
- • Taking antiplatelet drug or anticoagulant
About E Da Hospital
E-Da Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. With a commitment to patient safety and ethical standards, the hospital fosters a collaborative environment that integrates cutting-edge technology with comprehensive medical expertise. E-Da Hospital focuses on a wide range of therapeutic areas, aiming to improve treatment outcomes and enhance the quality of life for patients. Through its robust clinical trial program, the hospital actively contributes to the development of new therapies and interventions, ensuring that the latest advancements in medicine are accessible to the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung City, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials